Range
25.3 - 26.38
Vol / Avg.
200.4K/395.4K
Div / Yield
-
52 Wk
23.79 - 67.74
Mkt Cap
729.9M
Payout Ratio
-
Open
25.56
P/E
-
EPS
-1.08
Shares
27.8M
Outstanding
27.8M
Total Float
18.3M
Benzinga - 1 day ago
Benzinga - 2 days ago
Benzinga - Jun 28, 2021, 6:13AM
Benzinga - Jun 23, 2021, 8:30AM
Benzinga - Jun 23, 2021, 7:40AM
Benzinga - Jun 23, 2021, 7:20AM
Benzinga - Jun 22, 2021, 4:21PM
Benzinga - Jun 22, 2021, 4:17PM
Benzinga - Jun 7, 2021, 12:11PM
Benzinga - Jun 7, 2021, 11:11AM
Benzinga - Jun 1, 2021, 6:46AM
Benzinga - May 19, 2021, 8:11AM
load more
Sector: Health Care.Industry: Biotechnology
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-10
REV
Q1 2021Est.ActualSurprise
EPS-0.940-1.080 -0.1400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BTAIBioXcel Therapeutics3.99%729.9M

BioXcel Therapeutics Frequently Asked Questions

Q

How do I buy BioXcel Therapeutics (BTAI) stock?

A

You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioXcel Therapeutics's (BTAI) competitors?

A

Other companies in BioXcel Therapeutics’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Curis (NASDAQ:CRIS), Syndax Pharmaceuticals (NASDAQ:SNDX) and Immatics (NASDAQ:IMTX).

Q

What is the target price for BioXcel Therapeutics (BTAI) stock?

A

The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by HC Wainwright & Co. on June 28, 2021. The analyst firm set a price target for 140.00 expecting BTAI to rise to within 12 months (a possible 432.97% upside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BioXcel Therapeutics (BTAI)?

A

The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $26.268 last updated Today at 6:49:39 PM.

Q

Does BioXcel Therapeutics (BTAI) pay a dividend?

A

There are no upcoming dividends for BioXcel Therapeutics.

Q

When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?

A
BioXcel Therapeutics’s Q2 earnings are confirmed for after-market on August 10, 2021.
Q

Is BioXcel Therapeutics (BTAI) going to split?

A

There is no upcoming split for BioXcel Therapeutics.

Q

What sector and industry does BioXcel Therapeutics (BTAI) operate in?

A

BioXcel Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.